vs
Side-by-side financial comparison of AMICUS THERAPEUTICS, INC. (FOLD) and Porch Group, Inc. (PRCH). Click either name above to swap in a different company.
AMICUS THERAPEUTICS, INC. is the larger business by last-quarter revenue ($185.2M vs $121.1M, roughly 1.5× Porch Group, Inc.). AMICUS THERAPEUTICS, INC. runs the higher net margin — 0.9% vs -3.9%, a 4.8% gap on every dollar of revenue. On growth, Porch Group, Inc. posted the faster year-over-year revenue change (100.0% vs 23.7%). Over the past eight quarters, AMICUS THERAPEUTICS, INC.'s revenue compounded faster (29.5% CAGR vs 26.4%).
Amicus Therapeutics, Inc. is a public American biopharmaceutical company based in Philadelphia, Pennsylvania. The company went public in 2007 under the Nasdaq trading symbol FOLD. This followed a 2006 planned offering and subsequent withdrawal, which would have established the trading symbol as AMTX Prior to their IPO, Amicus was funded by a variety of venture capital firms including Radius Ventures, Canaan Partners and New Enterprise Associates.
Porch is a website that tries to connect homeowners with local home improvement contractors. The site features advice articles, cost guide, and online booking for over 160 home projects.
FOLD vs PRCH — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $185.2M | $121.1M |
| Net Profit | $1.7M | $-4.7M |
| Gross Margin | 85.7% | 52.7% |
| Operating Margin | 8.6% | 34.7% |
| Net Margin | 0.9% | -3.9% |
| Revenue YoY | 23.7% | 100.0% |
| Net Profit YoY | -88.5% | 2.0% |
| EPS (diluted) | $0.00 | $-0.04 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $121.1M | ||
| Q4 25 | $185.2M | $112.3M | ||
| Q3 25 | $169.1M | $115.1M | ||
| Q2 25 | $154.7M | $107.0M | ||
| Q1 25 | $125.2M | $84.5M | ||
| Q4 24 | $149.7M | $75.3M | ||
| Q3 24 | $141.5M | $77.7M | ||
| Q2 24 | $126.7M | $75.9M |
| Q1 26 | — | $-4.7M | ||
| Q4 25 | $1.7M | $-3.5M | ||
| Q3 25 | $17.3M | $-10.9M | ||
| Q2 25 | $-24.4M | $2.6M | ||
| Q1 25 | $-21.7M | $8.4M | ||
| Q4 24 | $14.7M | $30.5M | ||
| Q3 24 | $-6.7M | $14.4M | ||
| Q2 24 | $-15.7M | $-64.3M |
| Q1 26 | — | 52.7% | ||
| Q4 25 | 85.7% | 99.5% | ||
| Q3 25 | 88.5% | 75.6% | ||
| Q2 25 | 90.2% | 70.9% | ||
| Q1 25 | 90.7% | 77.4% | ||
| Q4 24 | 90.1% | — | ||
| Q3 24 | 90.6% | 79.4% | ||
| Q2 24 | 91.1% | 22.1% |
| Q1 26 | — | 34.7% | ||
| Q4 25 | 8.6% | 14.7% | ||
| Q3 25 | 20.3% | 14.2% | ||
| Q2 25 | -6.1% | 4.7% | ||
| Q1 25 | -6.3% | -1.5% | ||
| Q4 24 | 10.7% | 33.3% | ||
| Q3 24 | 15.3% | -3.2% | ||
| Q2 24 | 11.8% | -69.2% |
| Q1 26 | — | -3.9% | ||
| Q4 25 | 0.9% | -3.1% | ||
| Q3 25 | 10.2% | -9.4% | ||
| Q2 25 | -15.8% | 2.4% | ||
| Q1 25 | -17.3% | 9.9% | ||
| Q4 24 | 9.8% | 40.5% | ||
| Q3 24 | -4.8% | 18.5% | ||
| Q2 24 | -12.4% | -84.8% |
| Q1 26 | — | $-0.04 | ||
| Q4 25 | $0.00 | $0.00 | ||
| Q3 25 | $0.06 | $-0.10 | ||
| Q2 25 | $-0.08 | $0.00 | ||
| Q1 25 | $-0.07 | $0.07 | ||
| Q4 24 | $0.05 | $0.34 | ||
| Q3 24 | $-0.02 | $0.12 | ||
| Q2 24 | $-0.05 | $-0.65 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $293.5M | $68.4M |
| Total DebtLower is stronger | $392.7M | $391.3M |
| Stockholders' EquityBook value | $274.2M | $26.3M |
| Total Assets | $949.9M | $806.6M |
| Debt / EquityLower = less leverage | 1.43× | 14.87× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $68.4M | ||
| Q4 25 | $293.5M | $57.3M | ||
| Q3 25 | $263.8M | $85.0M | ||
| Q2 25 | $231.0M | $79.8M | ||
| Q1 25 | $250.6M | $70.4M | ||
| Q4 24 | $249.9M | $191.7M | ||
| Q3 24 | $249.8M | $238.6M | ||
| Q2 24 | $260.1M | $308.4M |
| Q1 26 | — | $391.3M | ||
| Q4 25 | $392.7M | $392.8M | ||
| Q3 25 | $392.0M | $387.1M | ||
| Q2 25 | $391.3M | $394.1M | ||
| Q1 25 | $390.7M | $409.2M | ||
| Q4 24 | $390.1M | $403.9M | ||
| Q3 24 | $389.5M | $399.0M | ||
| Q2 24 | $388.9M | $436.8M |
| Q1 26 | — | $26.3M | ||
| Q4 25 | $274.2M | $-24.6M | ||
| Q3 25 | $230.4M | $-27.9M | ||
| Q2 25 | $204.3M | $-29.3M | ||
| Q1 25 | $193.6M | $-52.4M | ||
| Q4 24 | $194.0M | $-43.2M | ||
| Q3 24 | $178.8M | $-77.0M | ||
| Q2 24 | $132.5M | $-101.9M |
| Q1 26 | — | $806.6M | ||
| Q4 25 | $949.9M | $797.4M | ||
| Q3 25 | $868.8M | $787.7M | ||
| Q2 25 | $815.3M | $770.7M | ||
| Q1 25 | $789.8M | $802.3M | ||
| Q4 24 | $785.0M | $814.0M | ||
| Q3 24 | $786.6M | $867.3M | ||
| Q2 24 | $749.5M | $876.1M |
| Q1 26 | — | 14.87× | ||
| Q4 25 | 1.43× | — | ||
| Q3 25 | 1.70× | — | ||
| Q2 25 | 1.92× | — | ||
| Q1 25 | 2.02× | — | ||
| Q4 24 | 2.01× | — | ||
| Q3 24 | 2.18× | — | ||
| Q2 24 | 2.93× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $16.3M | — |
| Free Cash FlowOCF − Capex | $16.0M | — |
| FCF MarginFCF / Revenue | 8.6% | — |
| Capex IntensityCapex / Revenue | 0.2% | — |
| Cash ConversionOCF / Net Profit | 9.62× | — |
| TTM Free Cash FlowTrailing 4 quarters | $29.8M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $16.3M | $1.2M | ||
| Q3 25 | $35.7M | $40.8M | ||
| Q2 25 | $-26.5M | $35.6M | ||
| Q1 25 | $7.8M | $-11.2M | ||
| Q4 24 | $-3.9M | $-26.6M | ||
| Q3 24 | $-23.0M | $12.4M | ||
| Q2 24 | $22.7M | $-26.0M |
| Q1 26 | — | — | ||
| Q4 25 | $16.0M | $1.1M | ||
| Q3 25 | $35.3M | $40.7M | ||
| Q2 25 | $-28.9M | $35.4M | ||
| Q1 25 | $7.5M | $-11.2M | ||
| Q4 24 | $-4.2M | $-26.8M | ||
| Q3 24 | $-23.3M | $12.2M | ||
| Q2 24 | $21.6M | $-26.0M |
| Q1 26 | — | — | ||
| Q4 25 | 8.6% | 1.0% | ||
| Q3 25 | 20.9% | 35.4% | ||
| Q2 25 | -18.7% | 33.0% | ||
| Q1 25 | 6.0% | -13.3% | ||
| Q4 24 | -2.8% | -35.6% | ||
| Q3 24 | -16.5% | 15.7% | ||
| Q2 24 | 17.0% | -34.3% |
| Q1 26 | — | — | ||
| Q4 25 | 0.2% | 0.1% | ||
| Q3 25 | 0.2% | 0.1% | ||
| Q2 25 | 1.6% | 0.2% | ||
| Q1 25 | 0.2% | 0.1% | ||
| Q4 24 | 0.2% | 0.3% | ||
| Q3 24 | 0.3% | 0.3% | ||
| Q2 24 | 0.9% | 0.1% |
| Q1 26 | — | — | ||
| Q4 25 | 9.62× | — | ||
| Q3 25 | 2.06× | — | ||
| Q2 25 | — | 13.79× | ||
| Q1 25 | — | -1.33× | ||
| Q4 24 | -0.27× | -0.87× | ||
| Q3 24 | — | 0.86× | ||
| Q2 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FOLD
| Other | $105.8M | 57% |
| Galafold | $64.8M | 35% |
| Pombiliti Opfolda | $14.6M | 8% |
PRCH
Segment breakdown not available.
